Search

Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research

Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 23 Year: 2016 Page: 2577-2604
Author(s): Mafalda Castro,Marco Preto,Vitor Vasconcelos,Ralph Urbatzka

Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors

Journal: Current Medicinal Chemistry
Volume: 23 Issue: 8 Year: 2016 Page: 832-849
Author(s): Yang Zhang, Zhao-Peng Liu

Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related Drugs

Journal: Current Medicinal Chemistry
Volume: 23 Issue: 2 Year: 2016 Page: 3044-3051
Author(s): Hideaki Kaneto, Atsushi Obata, Masashi Shimoda, Tomohiko Kimura, Hidenori Hirukawa, Seizo Okauchi, Taka-aki Matsuoka, Kohei Kaku

Journal: Current Diabetes Reviews
Volume: 12 Issue: 4 Year: 2016 Page: 429-439
Author(s): Thomas Forst, Tim Heise, Leona Plum-Morschel

Exploring Natural Products as a Source for Antidiabetic Lead Compounds and Possible Lead Optimization

Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 23 Year: 2016 Page: 2549-2561
Author(s): Reema Abu Khalaf

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 4 Year: 2016 Page: 316-318
Author(s): Nikolaos Papanas, Costas Tsioufis, Efstratios S. Maltezos

Perspectives on Phytochemicals as Antibacterial Agents: An Outstanding Contribution to Modern Therapeutics

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16 Issue: 4 Year: 2016 Page: 290-308
Author(s): Savita Khatri,Manish Kumar,Neetu Phougat,Renu Chaudhary,Anil Kumar Chhillar

Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 494-497
Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis

Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 469-473
Author(s): Vasilios G. Athyros, Niki Katsiki, Nikolaos Tentolouris

Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies

Journal: Current Drug Targets
Volume: 17 Issue: 11 Year: 2016 Page: 1309-1328
Author(s): Krishna A. Adeshara,Arundhati G. Diwan,Rashmi S. Tupe